Galderma logo

Medical Affairs Manager, Cetaphil

Galderma

Miami, FLHybridPosted 2 days ago$112,000 - $140,000 per year
Full TimeSenior LevelMedical AffairsPharmaceutical
Original posting ↗

Summary

Translate U.S. Medical Affairs strategy into executable scientific plans and deliverables for the Dermatological Skincare portfolio, with primary responsibility for Cetaphil and secondary support for other over-the-counter brands. Lead publication planning and execution, scientific content development, and scientific and promotional review through PRC/SRC. Manage assigned projects from planning through delivery, coordinating internal stakeholders, agencies, authors, vendors, and external experts. Act as the scientific expert and evidence-based authority for assigned brands, ensuring medical and commercial activities appropriately reflect the available data and scientific consensus.

Job description

The Opportunity

Translate U.S. Medical Affairs strategy into executable scientific plans and deliverables for the Dermatological Skincare portfolio, with primary responsibility for Cetaphil and secondary support for other over-the-counter brands. Lead publication planning and execution, scientific content development, and scientific and promotional review through PRC/SRC. Manage assigned projects from planning through delivery, coordinating internal stakeholders, agencies, authors, vendors, and external experts. Act as the scientific expert and evidence-based authority for assigned brands, ensuring medical and commercial activities appropriately reflect the available data and scientific consensus.

Key Responsibilities

Medical strategy execution

  • Translate U.S. medical strategies into practical tactical plans, milestones, deliverables, and measures of success.
  • Lead execution of assigned Cetaphil medical initiatives and support other Dermatological Skincare and OTC priorities as assigned.
  • Maintain clear project plans, ownership, decisions, timelines, dependencies, and risks.
  • Identify execution challenges early and recommend solutions or corrective actions.
  • Contribute to annual medical planning, scientific platform development, and evidence-generation priorities.
  • Provide concise, decision-oriented updates to the Director and relevant stakeholders.

Publication strategy and execution

  • Provide strategic and operational leadership for assigned publication plans.
  • Manage publication workstreams from concept development through congress submission, manuscript submission, revision, and publication.
  • Coordinate authors, external experts, agencies, internal reviewers, and publication vendors.
  • Recommend publication objectives, formats, target congresses, target journals, authorship approaches, and timelines.
  • Draft, review, and improve publication outlines and content for scientific quality, accuracy, balance, and strategic relevance.
  • Maintain publication plans and communicate progress, decisions, risks, and required actions.
  • Ensure publication activities follow applicable company procedures, authorship standards, and scientific integrity requirements.

Scientific communications and deck development

  • Lead the development and maintenance of medical decks, training materials, and other medical resources.
  • Translate clinical data, real-world evidence, formulation science, and peer-reviewed literature into accurate and useful scientific communications.
  • Maintain clear source documentation and referencing for scientific statements.
  • Ensure materials remain current and aligned with the available evidence and approved data.
  • Collaborate with Medical, Commercial, agency, and other authorized partners to support aligned scientific communication and execution.
  • Develop and deliver scientific training for Medical, Commercial, agency, and other authorized audiences, as appropriate.

PRC/SRC and medical review

  • Serve as a principal Medical Affairs reviewer for Cetaphil and Differin in PRC, SRC, and related review processes.
  • Lead scientific and promotional review of commercial and medical materials for accuracy, balance, substantiation, and appropriate use of evidence.
  • Escalate material scientific disagreements, compliance risks, or reputational concerns to the Director and appropriate review partners.

Evidence generation

Support planning and execution of assigned evidence generation initiatives, coordinating vendors, investigators, and internal stakeholders while contributing to study design, execution, and dissemination plans.

External scientific engagement

  • Support selected advisory boards, steering committees, round tables, congress activities, and other scientific engagements.
  • Participate in select external meetings when Medical Affairs coverage is required and aligned with role priorities.
  • Capture relevant insights and convert them into clear recommendations or follow-up actions.
  • Travel only as required for priority scientific activities.

Qualifications

Required: 5–8 years of relevant experience in Medical Affairs, publications, medical communications, medical review, evidence generation, or related scientific functions. Demonstrated experience managing complex scientific projects. Substantive publication leadership and scientific writing experience. Experience reviewing promotional and non-promotional materials. Dermatology, skincare, Consumer Health, or related therapeutic experience strongly preferred. Experience working with agencies, authors, external experts, and cross-functional review teams. Experience spanning consumer and prescription environments is preferred. Terminal scientific or clinical degree required (PhD, PharmD, MD, DO, or equivalent). Dermatology, skincare, clinical research, or Medical Affairs experience preferred.

Physical Requirements and Work Environment

This role requires the ability to perform standard office activities, including extended periods of computer use, participation in virtual and in-person meetings, and collaboration across teams. Depending on business needs, occasional travel may be required. Miami-based position. Expected to work from the designated Miami office 3–4 days per week, subject to applicable Galderma policy and local requirements. Minimal travel, primarily for selected priority congresses, advisory boards, scientific meetings, or evidence-generation activities. This is principally a home-office Medical Affairs strategy and execution role, not a field-based MSL position.

Requirements

  • 5–8 years of relevant experience in Medical Affairs, publications, medical communications, medical review, evidence generation, or related scientific functions
  • Demonstrated experience managing complex scientific projects
  • Substantive publication leadership and scientific writing experience
  • Experience reviewing promotional and non-promotional materials
  • Experience working with agencies, authors, external experts, and cross-functional review teams
  • Terminal scientific or clinical degree required (PhD, PharmD, MD, DO, or equivalent)
  • Dermatology, skincare, Consumer Health, or related therapeutic experience strongly preferred
  • Experience spanning consumer and prescription environments is preferred
  • Dermatology, skincare, clinical research, or Medical Affairs experience preferred

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Paid Time Off
  • Annual Incentive Program

Company overview

Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.